Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
about
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartHydrogen Peroxide Triggers a Dual Signaling Axis To Selectively Suppress Activated Human T Lymphocyte Migration.Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracilCXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii.Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model.Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral AttachmentInternational Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.Activation of CXCL10/CXCR3 signaling attenuates morphine analgesia: involvement of Gi protein.CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.Prospects for combined use of oncolytic viruses and CAR T-cells.Granulomatous lung inflammation is nanoparticle type-dependent.Identification of Two Distinct Sites for Antagonist and Biased Agonist Binding to the Human Chemokine Receptor CXCR3.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration.
P2860
Q28079006-FE6E0938-85D3-415A-A951-D07584310126Q30845438-65684D2E-7E61-45ED-830D-84E0BC6A06D6Q33990012-4DF746B9-B2B2-4EC1-BBC5-8A1EABD81F1EQ35008494-AFEF1EB9-E26B-4E14-9A65-B22EC9F1C633Q36464500-E32F2D9A-D25D-4FC7-A463-1663079517D4Q36771807-9B1CD498-0029-49ED-B35F-8C6E54CABCC8Q37046628-0BFA5B22-FC23-4FEB-A690-5131CA45160EQ37062259-E7080735-CFA6-4BB2-99B1-1FB12BED2E5CQ37432097-5E018428-2692-4EF2-A954-3EFBE89D9C20Q39029960-7E3DE15B-FE2D-49C3-9FBF-9721ECD3E371Q39213778-324124BC-76F2-44C9-A582-E0AFF496C30BQ39501428-D444118B-73A2-4B37-B718-7BECD94D2A46Q41628251-2FA0614F-C627-4226-9400-6526C459EEFCQ44817276-39054C9C-2C60-492B-B0AD-78BF1FC34FDAQ45077383-4E329427-3343-46DA-A5E7-C4503314C16BQ45931583-2CF4DAD5-3C46-4487-802F-2EB880F264FAQ47103891-02D47AD7-F691-41EF-A97C-6E2100F2CDD6Q47659888-107F7B65-87D0-45BE-966F-3D464BFDCC31Q48215156-0FA27BC4-31D3-4294-B3C2-140CB0D5B9DDQ49524220-15C2FBC2-2F08-4237-B6A0-9C40E23FDFA5Q50970453-5CF1A14A-519D-4919-993E-A110CFAE9D7AQ55365331-25A113FD-2DD9-4EC4-952A-A4F6CDEA3EA2
P2860
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
@en
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
@nl
type
label
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
@en
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
@nl
prefLabel
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
@en
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
@nl
P2860
P50
P1433
P1476
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
@en
P2093
Andrew J McKnight
Anna Korniejewska
P2860
P304
P356
10.1111/J.1365-2567.2010.03384.X
P577
2011-01-24T00:00:00Z